Management guidelines for primary lung cancer 2018: Chinese standards in clinical practice

详细信息    查看全文 | 推荐本文 |

英文篇名：Management guidelines for primary lung cancer 2018: Chinese standards in clinical practice 作者：Chao ; Lyu ; Nan ; Wu 英文作者：Chao Lyu;Nan Wu;Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute; 中文刊名：ZHAY 英文刊名：中国癌症研究(英文版) 机构：Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute; 出版日期：2019-06-15 出版单位：Chinese Journal of Cancer Research 年：2019 期：v.31 语种：英文; 页：ZHAY201903001 页数：2 CN：03 ISSN：11-2591/R 分类号：5-6

摘要

<正>Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 are a set of clinical standards for screening, diagnosis and treatment of lung cancer in China(1). It covers the specialties of epidemiology, radiology pathology, surgery, medical oncology, radiotherapy endoscopy, nuclear medicine, and so on. The guidelines are referred to by physicians, medical students and patients through providing comprehensive and detailed knowledge and recommendations in clinical practice on lung cancer diagnosis and treatment.The guidelines are featured by its design and contents First, it highlights the clinical symptoms related to lung cancer, physical examination, laboratory examinations and radiographic characteristics of lung cancer. This is different from that of National Comprehensive Cancer Network
        

引文

1.National Health Commission of the People’s Republic of China.Chinese guidelines for diagnosis and treatment of primary lung cancer 2018(English version).Chin J Cancer Res 2019;31:1-28.